Company news
Genflow Biosciences Plc (LSE:GENF) news
Genflow Biosciences Plc news releases on 6ix. Latest, Oct 5, 2026: Genflow Biosciences PLC Announces Presentation of Interim Results
Press releases & updates
Genflow Biosciences PLC Announces Presentation of Interim Results
October 5, 2026
Presentation of Interim Results
October 5, 2026
Genflow Biosciences PLC Announces Half-year Financial Report
September 29, 2026
Genflow Biosciences PLC Announces Primary Endpoint in SLAB Clinical Trial Met
September 8, 2026
Genflow Biosciences PLC Announces Appointment of Investor Relations Adviser
September 7, 2026
Genflow Biosciences PLC Announces Patent Update
August 3, 2026
Genflow Biosciences PLC Announces Mid-Year Operational and Corporate Summary
July 13, 2026
Genflow Biosciences PLC Announces Result of AGM
June 29, 2026
Genflow Biosciences PLC Announces Participation at BIO International Convention 2026
June 22, 2026
Company to present at Animal Longevity Summit 2026
June 17, 2026
Genflow Biosciences PLC Announces Notice of AGM
June 4, 2026
Exercise of Warrants and Issue of Equity
May 8, 2026
Expansion of Confidentiality Agreements
April 28, 2026
Genflow Biosciences PLC Announces Strategic Technology Collaboration
April 20, 2026
International Patent Publication
April 13, 2026
Update on the Dog Study
April 8, 2026
Total Voting Rights
March 31, 2026
Genflow Biosciences PLC Announces Issue of Equity & PDMR Notifications
March 5, 2026
Genflow Biosciences PLC Announces Result of GM
March 2, 2026
Genflow Biosciences PLC Announces Receipt of First Tranche of Grant
March 2, 2026
Genflow Biosciences PLC Announces Preliminary Interim Results From Dog Study
February 12, 2026
Notice of GM
February 11, 2026
Genflow Biosciences PLC Announces Notice of GM
February 11, 2026
Genflow Biosciences PLC Announces Holding(s) in Company
January 30, 2026
Holding(s) in Company
January 30, 2026
Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities
January 28, 2026
Genflow Biosciences PLC Announces Directorate Change
January 19, 2026
Directorate change
January 19, 2026
Review of 2025
January 8, 2026
Genflow Completes Dosing Phase of Canine Gene Therapy Trial
December 16, 2025
Completion of Dosing Phase of Canine Gene Therapy
December 16, 2025
Genflow to Attend Healthcare Conference
December 11, 2025
Genflow Biosciences PLC Announces Total Voting Rights
October 31, 2025
Second European Patent Application
October 22, 2025
Genflow Biosciences PLC Announces Second European Patent Application
October 22, 2025
Recognition of Patentability of Claims
October 20, 2025
Genflow Biosciences PLC Announces Recognition of Patentability of Claims
October 20, 2025
Update on Animal Health Program
October 10, 2025
Genflow Biosciences PLC Announces Update on Animal Health Program
October 10, 2025
Update, Equity Issue and PDMR Notification
October 9, 2025
Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification
October 9, 2025
Correction - Genflow Biosciences PLC Announces Issue of Equity
October 2, 2025
Issue of Equity - Correction
October 2, 2025
Genflow Biosciences PLC Announces Issue of Equity
October 2, 2025
Issue of Equity
October 2, 2025
Half-year Report
September 30, 2025
Genflow Biosciences PLC Announces Half-Year Report
September 30, 2025
Genflow Strengthens IP Portfolio
September 19, 2025
Genflow Signs CDAs with Animal Health Companies
September 15, 2025
Genflow Biosciences PLC Announces Company Update on Dog Trials
August 18, 2025